• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非肥胖非酒精性脂肪性肝病的运动和饮食调整:对活体肝供体肝活检的分析。

Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors.

机构信息

Department of Internal Medicine, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

J Gastroenterol Hepatol. 2012 Aug;27(8):1341-7. doi: 10.1111/j.1440-1746.2012.07165.x.

DOI:10.1111/j.1440-1746.2012.07165.x
PMID:22554085
Abstract

BACKGROUND AND AIMS

We evaluated efficacy of exercise and diet modification for steatosis improvement of non-obese non-alcoholic fatty liver disease (NAFLD) patients.

METHODS

We analyzed retrospectively the clinical and histological parameters of consecutive living liver donors, who experienced repeated liver biopsies due to steatosis and were treated using exercise and diet modification.

RESULTS

From 1995 to 2009, among a total of 1365 potential living liver donors with NAFLD seen on the initial liver biopsy, 120 consecutive donors with steatosis ≥ 30% or an estimated donor-recipient weight ratio < 0.8, underwent exercise and diet modification and received follow-up liver biopsy at our institution. Median age was 33 years, and median interval between the two consecutive biopsies was 10 weeks (range, 1-39). At the time of initial biopsy, the number of normal body mass index, overweight, and obese donors was 49 (40.8%), 65 (54.2%), and 6 (5.0%), respectively. After lifestyle modification, weight reduction and steatosis improvement were observed in 92 (76.7%) and 103 (85.8%) donors, respectively, at the time of follow-up biopsy. On multivariate analysis, initially higher steatosis (hazard ratio [HR] 1.03, P = 0.02), total cholesterol reduction ≥ 10% (HR 5.59, P = 0.02), and weight reduction ≥ 5% (HR 6.63, P = 0.03) were significantly associated with ≥ 20% steatosis improvement in 120 donors with NAFLD, after exercise and diet modification.

CONCLUSIONS

Exercise and diet modification were effective in reducing steatosis in potential living liver donors with non-obese NAFLD. Total cholesterol reduction ≥ 10% could be used as a non-invasive predictor for steatosis improvement in liver donors with NAFLD, after exercise and diet modification.

摘要

背景与目的

我们评估了运动和饮食改变对非肥胖非酒精性脂肪性肝病(NAFLD)患者肝脂肪变性改善的疗效。

方法

我们回顾性分析了因脂肪变性而接受重复肝活检且接受运动和饮食改变治疗的连续活体肝供者的临床和组织学参数。

结果

1995 年至 2009 年,在总共 1365 名接受初始肝活检的具有 NAFLD 的潜在活体肝供者中,120 名连续供者的脂肪变性≥30%或估计供体-受体体重比<0.8,在我们的机构接受运动和饮食改变并接受随访肝活检。中位年龄为 33 岁,两次连续活检之间的中位间隔为 10 周(范围 1-39)。在初始活检时,正常体重指数、超重和肥胖供者的数量分别为 49(40.8%)、65(54.2%)和 6(5.0%)。在生活方式改变后,92(76.7%)和 103(85.8%)名供者在随访活检时分别观察到体重减轻和脂肪变性改善。多变量分析显示,初始脂肪变性较高(危险比 [HR] 1.03,P=0.02)、总胆固醇降低≥10%(HR 5.59,P=0.02)和体重减轻≥5%(HR 6.63,P=0.03)与 120 名接受运动和饮食改变的非肥胖 NAFLD 供者的脂肪变性改善≥20%显著相关。

结论

运动和饮食改变可有效降低非肥胖 NAFLD 活体肝供者的脂肪变性。总胆固醇降低≥10%可作为运动和饮食改变后 NAFLD 肝供者脂肪变性改善的非侵入性预测指标。

相似文献

1
Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors.非肥胖非酒精性脂肪性肝病的运动和饮食调整:对活体肝供体肝活检的分析。
J Gastroenterol Hepatol. 2012 Aug;27(8):1341-7. doi: 10.1111/j.1440-1746.2012.07165.x.
2
Treatment of rapid weight loss in a donor with hepatic steatosis in living donor liver transplantation: a case report.活体肝移植中供体肝脂肪变性伴快速体重减轻的治疗:一例报告
Hepatogastroenterology. 2012 May;59(115):869-71. doi: 10.5754/hge10237.
3
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center.韩国潜在活体肝供体中非酒精性脂肪性肝病的患病率及危险因素:对单一中心589例连续肝活检的回顾
J Hepatol. 2007 Aug;47(2):239-44. doi: 10.1016/j.jhep.2007.02.007. Epub 2007 Mar 6.
4
High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.在非酒精性脂肪性肝病的生活方式干预期间,高心肺适能是肝脏脂肪减少的独立预测因素。
Gut. 2009 Sep;58(9):1281-8. doi: 10.1136/gut.2008.151977. Epub 2008 Dec 11.
5
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.非酒精性脂肪性肝病的疾病进展:一项 3 年时行肝活检配对的前瞻性研究。
Gut. 2010 Jul;59(7):969-74. doi: 10.1136/gut.2009.205088.
6
Correlation between hepatic steatosis, hepatic volume, and spleen volume in live liver donors.活体肝供者肝脏脂肪变性、肝脏体积与脾脏体积之间的相关性
Transplant Proc. 2008 Oct;40(8):2481-3. doi: 10.1016/j.transproceed.2008.08.045.
7
Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.体重减轻:非酒精性脂肪性肝病治疗的基石。
Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67.
8
Body mass index as a predictor of hepatic steatosis in living liver donors.体重指数作为活体肝供者肝脂肪变性的预测指标。
Liver Transpl. 2001 May;7(5):409-14. doi: 10.1053/jlts.2001.23787.
9
Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation.在活体肝移植初次就诊时,对存在脂肪肝的供体进行饮食治疗的安全性和可行性。
Transplantation. 2012 May 27;93(10):1024-30. doi: 10.1097/TP.0b013e31824c9e25.
10
Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests.健康潜在活体肝供体的肝活检结果:不合格原因、隐匿性疾病以及与肝损伤检测的相关性
J Hepatol. 2009 Mar;50(3):501-10. doi: 10.1016/j.jhep.2008.10.030. Epub 2008 Dec 29.

引用本文的文献

1
Increased Risk of Early-Onset Endometrial Cancer in Women Aged 20-39 Years with Non-Alcoholic Fatty Liver Disease: A Nationwide Cohort Study.20至39岁非酒精性脂肪性肝病女性患早发性子宫内膜癌的风险增加:一项全国性队列研究
Cancers (Basel). 2025 Apr 14;17(8):1322. doi: 10.3390/cancers17081322.
2
Increased risk of young-onset ovarian cancer in women with non-alcoholic fatty liver disease: A nationwide cohort study of 2.3 million women aged 20-39 years.非酒精性脂肪性肝病女性患早发性卵巢癌的风险增加:一项对230万20至39岁女性的全国性队列研究。
Sci Rep. 2025 Apr 25;15(1):14463. doi: 10.1038/s41598-025-99093-7.
3
Impact of Donor Obesity on Graft and Recipient Survival Outcomes After Liver Transplantation: A Systematic Review and Meta-analysis.
供体肥胖对肝移植后移植物和受者生存结局的影响:一项系统评价和荟萃分析
Transplant Direct. 2024 Aug 29;10(9):e1656. doi: 10.1097/TXD.0000000000001656. eCollection 2024 Sep.
4
Review of current and new drugs for the treatment of metabolic-associated fatty liver disease.治疗代谢相关脂肪性肝病的现有和新型药物的综述。
Hepatol Int. 2024 Oct;18(Suppl 2):977-989. doi: 10.1007/s12072-024-10698-y. Epub 2024 Jun 8.
5
Update in lean metabolic dysfunction-associated steatotic liver disease.瘦素代谢功能障碍相关脂肪性肝病的最新进展。
World J Hepatol. 2024 Mar 27;16(3):452-464. doi: 10.4254/wjh.v16.i3.452.
6
Donor body mass index over 30 is no barrier for pure laparoscopic donor right hepatectomy.供体体重指数超过30并非单纯腹腔镜供体右半肝切除术的障碍。
Ann Hepatobiliary Pancreat Surg. 2024 Aug 31;28(3):337-343. doi: 10.14701/ahbps.24-020. Epub 2024 Apr 3.
7
Non-alcoholic Steatohepatitis in Asians: Current Perspectives and Future Directions.亚洲人的非酒精性脂肪性肝炎:当前观点与未来方向
Cureus. 2023 Aug 2;15(8):e42852. doi: 10.7759/cureus.42852. eCollection 2023 Aug.
8
Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.瘦型非酒精性脂肪性肝病中的表观遗传调控。
Int J Mol Sci. 2023 Aug 16;24(16):12864. doi: 10.3390/ijms241612864.
9
The Association between Cardio-metabolic and hepatic indices and anthropometric measures with metabolically obesity phenotypes: a cross-sectional study from the Hoveyzeh Cohort Study.代谢性肥胖表型与心血管代谢和肝脏指数及人体测量学指标的关系:霍韦泽队列研究的横断面研究。
BMC Endocr Disord. 2023 May 29;23(1):122. doi: 10.1186/s12902-023-01372-9.
10
Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: A systematic review and meta-analysis.生活方式干预对代谢相关脂肪性肝病成人患者的影响:系统评价和荟萃分析。
Front Endocrinol (Lausanne). 2023 Feb 16;14:1081096. doi: 10.3389/fendo.2023.1081096. eCollection 2023.